Within the class S4 of hormone and metabolic modulators of the WADA Prohibited List, 39% of the adverse analytical findings (AAF) reported in 2020 resulted from SERMs (tamoxifen and clomiphene) and another 29% from AIs (letrozole, anastrozole, exemestane, and adrostatrienedione) ( Among the other PCT drugs, bromocriptine, which is similar to the popular cabergoline, an ergot alkaloid derivative used to treat hyperprolactinemia, is less common than cabergoline among AAS users during PCT owing to its many side effects, such as low blood pressure, dizziness, confusion, and nausea
Avram Registration number: 8502020912 Dr
Peptide Sciences, the GHK-Cu option Long-established US research peptide brand, inquire-only pricing
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone in vitro and in vivo